Global Myocardial Perfusion Imaging Testing Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
The global market for Myocardial Perfusion Imaging Testing is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Myocardial Perfusion Imaging Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Myocardial Perfusion Imaging Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Myocardial Perfusion Imaging Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Myocardial Perfusion Imaging Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Myocardial Perfusion Imaging Testing players cover Lantheus, Cardinal Health, GE Healthcare, Pharmalucence and Curium Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Myocardial Perfusion Imaging Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Myocardial Perfusion Imaging Testing market, with both quantitative and qualitative data, to help readers understand how the Myocardial Perfusion Imaging Testing market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Myocardial Perfusion Imaging Testing market and forecasts the market size by Type (Single Photon Emission Computed Tomography and Positron Emission Tomography,), by Application (Hospital, Ambulatory Care Centers and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Chapter 1: Scope of Myocardial Perfusion Imaging Testing, Research Methodology, etc.
Chapter 2: Executive Summary, global Myocardial Perfusion Imaging Testing market size (sales and revenue) and CAGR, Myocardial Perfusion Imaging Testing market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Myocardial Perfusion Imaging Testing sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Myocardial Perfusion Imaging Testing sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Myocardial Perfusion Imaging Testing market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Lantheus, Cardinal Health, GE Healthcare, Pharmalucence, Curium Pharma, Jubilant DraxImage, Atom-Hitech, Dongcheng Biochemicals and Jiangyuan Pharmaceutical, etc.
Chapter 14: Research Findings and Conclusion
The global market for Myocardial Perfusion Imaging Testing is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Myocardial Perfusion Imaging Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Myocardial Perfusion Imaging Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Myocardial Perfusion Imaging Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Myocardial Perfusion Imaging Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Myocardial Perfusion Imaging Testing players cover Lantheus, Cardinal Health, GE Healthcare, Pharmalucence and Curium Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Myocardial Perfusion Imaging Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Myocardial Perfusion Imaging Testing market, with both quantitative and qualitative data, to help readers understand how the Myocardial Perfusion Imaging Testing market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Myocardial Perfusion Imaging Testing market and forecasts the market size by Type (Single Photon Emission Computed Tomography and Positron Emission Tomography,), by Application (Hospital, Ambulatory Care Centers and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
- Single Photon Emission Computed Tomography
- Positron Emission Tomography
- Hospital
- Ambulatory Care Centers
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Lantheus
- Cardinal Health
- GE Healthcare
- Pharmalucence
- Curium Pharma
- Jubilant DraxImage
- Atom-Hitech
- Dongcheng Biochemicals
- Jiangyuan Pharmaceutical
Chapter 1: Scope of Myocardial Perfusion Imaging Testing, Research Methodology, etc.
Chapter 2: Executive Summary, global Myocardial Perfusion Imaging Testing market size (sales and revenue) and CAGR, Myocardial Perfusion Imaging Testing market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Myocardial Perfusion Imaging Testing sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Myocardial Perfusion Imaging Testing sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Myocardial Perfusion Imaging Testing market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Lantheus, Cardinal Health, GE Healthcare, Pharmalucence, Curium Pharma, Jubilant DraxImage, Atom-Hitech, Dongcheng Biochemicals and Jiangyuan Pharmaceutical, etc.
Chapter 14: Research Findings and Conclusion
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Myocardial Perfusion Imaging Testing Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Myocardial Perfusion Imaging Testing by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Myocardial Perfusion Imaging Testing by Country/Region, 2017, 2022 & 2028
2.2 Myocardial Perfusion Imaging Testing Segment by Type
2.2.1 Single Photon Emission Computed Tomography
2.2.2 Positron Emission Tomography
2.3 Myocardial Perfusion Imaging Testing Sales by Type
2.3.1 Global Myocardial Perfusion Imaging Testing Sales Market Share by Type (2017-2022)
2.3.2 Global Myocardial Perfusion Imaging Testing Revenue and Market Share by Type (2017-2022)
2.3.3 Global Myocardial Perfusion Imaging Testing Sale Price by Type (2017-2022)
2.4 Myocardial Perfusion Imaging Testing Segment by Application
2.4.1 Hospital
2.4.2 Ambulatory Care Centers
2.4.3 Others
2.5 Myocardial Perfusion Imaging Testing Sales by Application
2.5.1 Global Myocardial Perfusion Imaging Testing Sale Market Share by Application (2017-2022)
2.5.2 Global Myocardial Perfusion Imaging Testing Revenue and Market Share by Application (2017-2022)
2.5.3 Global Myocardial Perfusion Imaging Testing Sale Price by Application (2017-2022)
3 GLOBAL MYOCARDIAL PERFUSION IMAGING TESTING BY COMPANY
3.1 Global Myocardial Perfusion Imaging Testing Breakdown Data by Company
3.1.1 Global Myocardial Perfusion Imaging Testing Annual Sales by Company (2020-2022)
3.1.2 Global Myocardial Perfusion Imaging Testing Sales Market Share by Company (2020-2022)
3.2 Global Myocardial Perfusion Imaging Testing Annual Revenue by Company (2020-2022)
3.2.1 Global Myocardial Perfusion Imaging Testing Revenue by Company (2020-2022)
3.2.2 Global Myocardial Perfusion Imaging Testing Revenue Market Share by Company (2020-2022)
3.3 Global Myocardial Perfusion Imaging Testing Sale Price by Company
3.4 Key Manufacturers Myocardial Perfusion Imaging Testing Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Myocardial Perfusion Imaging Testing Product Location Distribution
3.4.2 Players Myocardial Perfusion Imaging Testing Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR MYOCARDIAL PERFUSION IMAGING TESTING BY GEOGRAPHIC REGION
4.1 World Historic Myocardial Perfusion Imaging Testing Market Size by Geographic Region (2017-2022)
4.1.1 Global Myocardial Perfusion Imaging Testing Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Myocardial Perfusion Imaging Testing Annual Revenue by Geographic Region
4.2 World Historic Myocardial Perfusion Imaging Testing Market Size by Country/Region (2017-2022)
4.2.1 Global Myocardial Perfusion Imaging Testing Annual Sales by Country/Region (2017-2022)
4.2.2 Global Myocardial Perfusion Imaging Testing Annual Revenue by Country/Region
4.3 Americas Myocardial Perfusion Imaging Testing Sales Growth
4.4 APAC Myocardial Perfusion Imaging Testing Sales Growth
4.5 Europe Myocardial Perfusion Imaging Testing Sales Growth
4.6 Middle East & Africa Myocardial Perfusion Imaging Testing Sales Growth
5 AMERICAS
5.1 Americas Myocardial Perfusion Imaging Testing Sales by Country
5.1.1 Americas Myocardial Perfusion Imaging Testing Sales by Country (2017-2022)
5.1.2 Americas Myocardial Perfusion Imaging Testing Revenue by Country (2017-2022)
5.2 Americas Myocardial Perfusion Imaging Testing Sales by Type
5.3 Americas Myocardial Perfusion Imaging Testing Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Myocardial Perfusion Imaging Testing Sales by Region
6.1.1 APAC Myocardial Perfusion Imaging Testing Sales by Region (2017-2022)
6.1.2 APAC Myocardial Perfusion Imaging Testing Revenue by Region (2017-2022)
6.2 APAC Myocardial Perfusion Imaging Testing Sales by Type
6.3 APAC Myocardial Perfusion Imaging Testing Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Myocardial Perfusion Imaging Testing by Country
7.1.1 Europe Myocardial Perfusion Imaging Testing Sales by Country (2017-2022)
7.1.2 Europe Myocardial Perfusion Imaging Testing Revenue by Country (2017-2022)
7.2 Europe Myocardial Perfusion Imaging Testing Sales by Type
7.3 Europe Myocardial Perfusion Imaging Testing Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Myocardial Perfusion Imaging Testing by Country
8.1.1 Middle East & Africa Myocardial Perfusion Imaging Testing Sales by Country (2017-2022)
8.1.2 Middle East & Africa Myocardial Perfusion Imaging Testing Revenue by Country (2017-2022)
8.2 Middle East & Africa Myocardial Perfusion Imaging Testing Sales by Type
8.3 Middle East & Africa Myocardial Perfusion Imaging Testing Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Myocardial Perfusion Imaging Testing
10.3 Manufacturing Process Analysis of Myocardial Perfusion Imaging Testing
10.4 Industry Chain Structure of Myocardial Perfusion Imaging Testing
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Myocardial Perfusion Imaging Testing Distributors
11.3 Myocardial Perfusion Imaging Testing Customer
12 WORLD FORECAST REVIEW FOR MYOCARDIAL PERFUSION IMAGING TESTING BY GEOGRAPHIC REGION
12.1 Global Myocardial Perfusion Imaging Testing Market Size Forecast by Region
12.1.1 Global Myocardial Perfusion Imaging Testing Forecast by Region (2023-2028)
12.1.2 Global Myocardial Perfusion Imaging Testing Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Myocardial Perfusion Imaging Testing Forecast by Type
12.7 Global Myocardial Perfusion Imaging Testing Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Lantheus
13.1.1 Lantheus Company Information
13.1.2 Lantheus Myocardial Perfusion Imaging Testing Product Offered
13.1.3 Lantheus Myocardial Perfusion Imaging Testing Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Lantheus Main Business Overview
13.1.5 Lantheus Latest Developments
13.2 Cardinal Health
13.2.1 Cardinal Health Company Information
13.2.2 Cardinal Health Myocardial Perfusion Imaging Testing Product Offered
13.2.3 Cardinal Health Myocardial Perfusion Imaging Testing Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Cardinal Health Main Business Overview
13.2.5 Cardinal Health Latest Developments
13.3 GE Healthcare
13.3.1 GE Healthcare Company Information
13.3.2 GE Healthcare Myocardial Perfusion Imaging Testing Product Offered
13.3.3 GE Healthcare Myocardial Perfusion Imaging Testing Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 GE Healthcare Main Business Overview
13.3.5 GE Healthcare Latest Developments
13.4 Pharmalucence
13.4.1 Pharmalucence Company Information
13.4.2 Pharmalucence Myocardial Perfusion Imaging Testing Product Offered
13.4.3 Pharmalucence Myocardial Perfusion Imaging Testing Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Pharmalucence Main Business Overview
13.4.5 Pharmalucence Latest Developments
13.5 Curium Pharma
13.5.1 Curium Pharma Company Information
13.5.2 Curium Pharma Myocardial Perfusion Imaging Testing Product Offered
13.5.3 Curium Pharma Myocardial Perfusion Imaging Testing Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Curium Pharma Main Business Overview
13.5.5 Curium Pharma Latest Developments
13.6 Jubilant DraxImage
13.6.1 Jubilant DraxImage Company Information
13.6.2 Jubilant DraxImage Myocardial Perfusion Imaging Testing Product Offered
13.6.3 Jubilant DraxImage Myocardial Perfusion Imaging Testing Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Jubilant DraxImage Main Business Overview
13.6.5 Jubilant DraxImage Latest Developments
13.7 Atom-Hitech
13.7.1 Atom-Hitech Company Information
13.7.2 Atom-Hitech Myocardial Perfusion Imaging Testing Product Offered
13.7.3 Atom-Hitech Myocardial Perfusion Imaging Testing Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Atom-Hitech Main Business Overview
13.7.5 Atom-Hitech Latest Developments
13.8 Dongcheng Biochemicals
13.8.1 Dongcheng Biochemicals Company Information
13.8.2 Dongcheng Biochemicals Myocardial Perfusion Imaging Testing Product Offered
13.8.3 Dongcheng Biochemicals Myocardial Perfusion Imaging Testing Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Dongcheng Biochemicals Main Business Overview
13.8.5 Dongcheng Biochemicals Latest Developments
13.9 Jiangyuan Pharmaceutical
13.9.1 Jiangyuan Pharmaceutical Company Information
13.9.2 Jiangyuan Pharmaceutical Myocardial Perfusion Imaging Testing Product Offered
13.9.3 Jiangyuan Pharmaceutical Myocardial Perfusion Imaging Testing Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Jiangyuan Pharmaceutical Main Business Overview
13.9.5 Jiangyuan Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Myocardial Perfusion Imaging Testing Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Myocardial Perfusion Imaging Testing by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Myocardial Perfusion Imaging Testing by Country/Region, 2017, 2022 & 2028
2.2 Myocardial Perfusion Imaging Testing Segment by Type
2.2.1 Single Photon Emission Computed Tomography
2.2.2 Positron Emission Tomography
2.3 Myocardial Perfusion Imaging Testing Sales by Type
2.3.1 Global Myocardial Perfusion Imaging Testing Sales Market Share by Type (2017-2022)
2.3.2 Global Myocardial Perfusion Imaging Testing Revenue and Market Share by Type (2017-2022)
2.3.3 Global Myocardial Perfusion Imaging Testing Sale Price by Type (2017-2022)
2.4 Myocardial Perfusion Imaging Testing Segment by Application
2.4.1 Hospital
2.4.2 Ambulatory Care Centers
2.4.3 Others
2.5 Myocardial Perfusion Imaging Testing Sales by Application
2.5.1 Global Myocardial Perfusion Imaging Testing Sale Market Share by Application (2017-2022)
2.5.2 Global Myocardial Perfusion Imaging Testing Revenue and Market Share by Application (2017-2022)
2.5.3 Global Myocardial Perfusion Imaging Testing Sale Price by Application (2017-2022)
3 GLOBAL MYOCARDIAL PERFUSION IMAGING TESTING BY COMPANY
3.1 Global Myocardial Perfusion Imaging Testing Breakdown Data by Company
3.1.1 Global Myocardial Perfusion Imaging Testing Annual Sales by Company (2020-2022)
3.1.2 Global Myocardial Perfusion Imaging Testing Sales Market Share by Company (2020-2022)
3.2 Global Myocardial Perfusion Imaging Testing Annual Revenue by Company (2020-2022)
3.2.1 Global Myocardial Perfusion Imaging Testing Revenue by Company (2020-2022)
3.2.2 Global Myocardial Perfusion Imaging Testing Revenue Market Share by Company (2020-2022)
3.3 Global Myocardial Perfusion Imaging Testing Sale Price by Company
3.4 Key Manufacturers Myocardial Perfusion Imaging Testing Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Myocardial Perfusion Imaging Testing Product Location Distribution
3.4.2 Players Myocardial Perfusion Imaging Testing Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR MYOCARDIAL PERFUSION IMAGING TESTING BY GEOGRAPHIC REGION
4.1 World Historic Myocardial Perfusion Imaging Testing Market Size by Geographic Region (2017-2022)
4.1.1 Global Myocardial Perfusion Imaging Testing Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Myocardial Perfusion Imaging Testing Annual Revenue by Geographic Region
4.2 World Historic Myocardial Perfusion Imaging Testing Market Size by Country/Region (2017-2022)
4.2.1 Global Myocardial Perfusion Imaging Testing Annual Sales by Country/Region (2017-2022)
4.2.2 Global Myocardial Perfusion Imaging Testing Annual Revenue by Country/Region
4.3 Americas Myocardial Perfusion Imaging Testing Sales Growth
4.4 APAC Myocardial Perfusion Imaging Testing Sales Growth
4.5 Europe Myocardial Perfusion Imaging Testing Sales Growth
4.6 Middle East & Africa Myocardial Perfusion Imaging Testing Sales Growth
5 AMERICAS
5.1 Americas Myocardial Perfusion Imaging Testing Sales by Country
5.1.1 Americas Myocardial Perfusion Imaging Testing Sales by Country (2017-2022)
5.1.2 Americas Myocardial Perfusion Imaging Testing Revenue by Country (2017-2022)
5.2 Americas Myocardial Perfusion Imaging Testing Sales by Type
5.3 Americas Myocardial Perfusion Imaging Testing Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Myocardial Perfusion Imaging Testing Sales by Region
6.1.1 APAC Myocardial Perfusion Imaging Testing Sales by Region (2017-2022)
6.1.2 APAC Myocardial Perfusion Imaging Testing Revenue by Region (2017-2022)
6.2 APAC Myocardial Perfusion Imaging Testing Sales by Type
6.3 APAC Myocardial Perfusion Imaging Testing Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Myocardial Perfusion Imaging Testing by Country
7.1.1 Europe Myocardial Perfusion Imaging Testing Sales by Country (2017-2022)
7.1.2 Europe Myocardial Perfusion Imaging Testing Revenue by Country (2017-2022)
7.2 Europe Myocardial Perfusion Imaging Testing Sales by Type
7.3 Europe Myocardial Perfusion Imaging Testing Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Myocardial Perfusion Imaging Testing by Country
8.1.1 Middle East & Africa Myocardial Perfusion Imaging Testing Sales by Country (2017-2022)
8.1.2 Middle East & Africa Myocardial Perfusion Imaging Testing Revenue by Country (2017-2022)
8.2 Middle East & Africa Myocardial Perfusion Imaging Testing Sales by Type
8.3 Middle East & Africa Myocardial Perfusion Imaging Testing Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Myocardial Perfusion Imaging Testing
10.3 Manufacturing Process Analysis of Myocardial Perfusion Imaging Testing
10.4 Industry Chain Structure of Myocardial Perfusion Imaging Testing
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Myocardial Perfusion Imaging Testing Distributors
11.3 Myocardial Perfusion Imaging Testing Customer
12 WORLD FORECAST REVIEW FOR MYOCARDIAL PERFUSION IMAGING TESTING BY GEOGRAPHIC REGION
12.1 Global Myocardial Perfusion Imaging Testing Market Size Forecast by Region
12.1.1 Global Myocardial Perfusion Imaging Testing Forecast by Region (2023-2028)
12.1.2 Global Myocardial Perfusion Imaging Testing Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Myocardial Perfusion Imaging Testing Forecast by Type
12.7 Global Myocardial Perfusion Imaging Testing Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Lantheus
13.1.1 Lantheus Company Information
13.1.2 Lantheus Myocardial Perfusion Imaging Testing Product Offered
13.1.3 Lantheus Myocardial Perfusion Imaging Testing Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Lantheus Main Business Overview
13.1.5 Lantheus Latest Developments
13.2 Cardinal Health
13.2.1 Cardinal Health Company Information
13.2.2 Cardinal Health Myocardial Perfusion Imaging Testing Product Offered
13.2.3 Cardinal Health Myocardial Perfusion Imaging Testing Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Cardinal Health Main Business Overview
13.2.5 Cardinal Health Latest Developments
13.3 GE Healthcare
13.3.1 GE Healthcare Company Information
13.3.2 GE Healthcare Myocardial Perfusion Imaging Testing Product Offered
13.3.3 GE Healthcare Myocardial Perfusion Imaging Testing Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 GE Healthcare Main Business Overview
13.3.5 GE Healthcare Latest Developments
13.4 Pharmalucence
13.4.1 Pharmalucence Company Information
13.4.2 Pharmalucence Myocardial Perfusion Imaging Testing Product Offered
13.4.3 Pharmalucence Myocardial Perfusion Imaging Testing Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Pharmalucence Main Business Overview
13.4.5 Pharmalucence Latest Developments
13.5 Curium Pharma
13.5.1 Curium Pharma Company Information
13.5.2 Curium Pharma Myocardial Perfusion Imaging Testing Product Offered
13.5.3 Curium Pharma Myocardial Perfusion Imaging Testing Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Curium Pharma Main Business Overview
13.5.5 Curium Pharma Latest Developments
13.6 Jubilant DraxImage
13.6.1 Jubilant DraxImage Company Information
13.6.2 Jubilant DraxImage Myocardial Perfusion Imaging Testing Product Offered
13.6.3 Jubilant DraxImage Myocardial Perfusion Imaging Testing Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Jubilant DraxImage Main Business Overview
13.6.5 Jubilant DraxImage Latest Developments
13.7 Atom-Hitech
13.7.1 Atom-Hitech Company Information
13.7.2 Atom-Hitech Myocardial Perfusion Imaging Testing Product Offered
13.7.3 Atom-Hitech Myocardial Perfusion Imaging Testing Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Atom-Hitech Main Business Overview
13.7.5 Atom-Hitech Latest Developments
13.8 Dongcheng Biochemicals
13.8.1 Dongcheng Biochemicals Company Information
13.8.2 Dongcheng Biochemicals Myocardial Perfusion Imaging Testing Product Offered
13.8.3 Dongcheng Biochemicals Myocardial Perfusion Imaging Testing Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Dongcheng Biochemicals Main Business Overview
13.8.5 Dongcheng Biochemicals Latest Developments
13.9 Jiangyuan Pharmaceutical
13.9.1 Jiangyuan Pharmaceutical Company Information
13.9.2 Jiangyuan Pharmaceutical Myocardial Perfusion Imaging Testing Product Offered
13.9.3 Jiangyuan Pharmaceutical Myocardial Perfusion Imaging Testing Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Jiangyuan Pharmaceutical Main Business Overview
13.9.5 Jiangyuan Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Myocardial Perfusion Imaging Testing Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Myocardial Perfusion Imaging Testing Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Single Photon Emission Computed Tomography
Table 4. Major Players of Positron Emission Tomography
Table 5. Global Myocardial Perfusion Imaging Testing Sales by Type (2017-2022) & (K Units)
Table 6. Global Myocardial Perfusion Imaging Testing Sales Market Share by Type (2017-2022)
Table 7. Global Myocardial Perfusion Imaging Testing Revenue by Type (2017-2022) & ($ million)
Table 8. Global Myocardial Perfusion Imaging Testing Revenue Market Share by Type (2017-2022)
Table 9. Global Myocardial Perfusion Imaging Testing Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Myocardial Perfusion Imaging Testing Sales by Application (2017-2022) & (K Units)
Table 11. Global Myocardial Perfusion Imaging Testing Sales Market Share by Application (2017-2022)
Table 12. Global Myocardial Perfusion Imaging Testing Revenue by Application (2017-2022)
Table 13. Global Myocardial Perfusion Imaging Testing Revenue Market Share by Application (2017-2022)
Table 14. Global Myocardial Perfusion Imaging Testing Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Myocardial Perfusion Imaging Testing Sales by Company (2020-2022) & (K Units)
Table 16. Global Myocardial Perfusion Imaging Testing Sales Market Share by Company (2020-2022)
Table 17. Global Myocardial Perfusion Imaging Testing Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Myocardial Perfusion Imaging Testing Revenue Market Share by Company (2020-2022)
Table 19. Global Myocardial Perfusion Imaging Testing Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Myocardial Perfusion Imaging Testing Producing Area Distribution and Sales Area
Table 21. Players Myocardial Perfusion Imaging Testing Products Offered
Table 22. Myocardial Perfusion Imaging Testing Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Myocardial Perfusion Imaging Testing Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Myocardial Perfusion Imaging Testing Sales Market Share Geographic Region (2017-2022)
Table 27. Global Myocardial Perfusion Imaging Testing Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Myocardial Perfusion Imaging Testing Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Myocardial Perfusion Imaging Testing Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Myocardial Perfusion Imaging Testing Sales Market Share by Country/Region (2017-2022)
Table 31. Global Myocardial Perfusion Imaging Testing Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Myocardial Perfusion Imaging Testing Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Myocardial Perfusion Imaging Testing Sales by Country (2017-2022) & (K Units)
Table 34. Americas Myocardial Perfusion Imaging Testing Sales Market Share by Country (2017-2022)
Table 35. Americas Myocardial Perfusion Imaging Testing Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Myocardial Perfusion Imaging Testing Revenue Market Share by Country (2017-2022)
Table 37. Americas Myocardial Perfusion Imaging Testing Sales by Type (2017-2022) & (K Units)
Table 38. Americas Myocardial Perfusion Imaging Testing Sales Market Share by Type (2017-2022)
Table 39. Americas Myocardial Perfusion Imaging Testing Sales by Application (2017-2022) & (K Units)
Table 40. Americas Myocardial Perfusion Imaging Testing Sales Market Share by Application (2017-2022)
Table 41. APAC Myocardial Perfusion Imaging Testing Sales by Region (2017-2022) & (K Units)
Table 42. APAC Myocardial Perfusion Imaging Testing Sales Market Share by Region (2017-2022)
Table 43. APAC Myocardial Perfusion Imaging Testing Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Myocardial Perfusion Imaging Testing Revenue Market Share by Region (2017-2022)
Table 45. APAC Myocardial Perfusion Imaging Testing Sales by Type (2017-2022) & (K Units)
Table 46. APAC Myocardial Perfusion Imaging Testing Sales Market Share by Type (2017-2022)
Table 47. APAC Myocardial Perfusion Imaging Testing Sales by Application (2017-2022) & (K Units)
Table 48. APAC Myocardial Perfusion Imaging Testing Sales Market Share by Application (2017-2022)
Table 49. Europe Myocardial Perfusion Imaging Testing Sales by Country (2017-2022) & (K Units)
Table 50. Europe Myocardial Perfusion Imaging Testing Sales Market Share by Country (2017-2022)
Table 51. Europe Myocardial Perfusion Imaging Testing Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Myocardial Perfusion Imaging Testing Revenue Market Share by Country (2017-2022)
Table 53. Europe Myocardial Perfusion Imaging Testing Sales by Type (2017-2022) & (K Units)
Table 54. Europe Myocardial Perfusion Imaging Testing Sales Market Share by Type (2017-2022)
Table 55. Europe Myocardial Perfusion Imaging Testing Sales by Application (2017-2022) & (K Units)
Table 56. Europe Myocardial Perfusion Imaging Testing Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Myocardial Perfusion Imaging Testing Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Myocardial Perfusion Imaging Testing Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Myocardial Perfusion Imaging Testing Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Myocardial Perfusion Imaging Testing Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Myocardial Perfusion Imaging Testing Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Myocardial Perfusion Imaging Testing Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Myocardial Perfusion Imaging Testing Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Myocardial Perfusion Imaging Testing Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Myocardial Perfusion Imaging Testing
Table 66. Key Market Challenges & Risks of Myocardial Perfusion Imaging Testing
Table 67. Key Industry Trends of Myocardial Perfusion Imaging Testing
Table 68. Myocardial Perfusion Imaging Testing Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Myocardial Perfusion Imaging Testing Distributors List
Table 71. Myocardial Perfusion Imaging Testing Customer List
Table 72. Global Myocardial Perfusion Imaging Testing Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Myocardial Perfusion Imaging Testing Sales Market Forecast by Region
Table 74. Global Myocardial Perfusion Imaging Testing Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Myocardial Perfusion Imaging Testing Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Myocardial Perfusion Imaging Testing Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Myocardial Perfusion Imaging Testing Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Myocardial Perfusion Imaging Testing Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Myocardial Perfusion Imaging Testing Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Myocardial Perfusion Imaging Testing Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Myocardial Perfusion Imaging Testing Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Myocardial Perfusion Imaging Testing Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Myocardial Perfusion Imaging Testing Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Myocardial Perfusion Imaging Testing Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Myocardial Perfusion Imaging Testing Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Myocardial Perfusion Imaging Testing Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Myocardial Perfusion Imaging Testing Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Myocardial Perfusion Imaging Testing Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Myocardial Perfusion Imaging Testing Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Myocardial Perfusion Imaging Testing Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Myocardial Perfusion Imaging Testing Revenue Market Share Forecast by Application (2023-2028)
Table 92. Lantheus Basic Information, Myocardial Perfusion Imaging Testing Manufacturing Base, Sales Area and Its Competitors
Table 93. Lantheus Myocardial Perfusion Imaging Testing Product Offered
Table 94. Lantheus Myocardial Perfusion Imaging Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Lantheus Main Business
Table 96. Lantheus Latest Developments
Table 97. Cardinal Health Basic Information, Myocardial Perfusion Imaging Testing Manufacturing Base, Sales Area and Its Competitors
Table 98. Cardinal Health Myocardial Perfusion Imaging Testing Product Offered
Table 99. Cardinal Health Myocardial Perfusion Imaging Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Cardinal Health Main Business
Table 101. Cardinal Health Latest Developments
Table 102. GE Healthcare Basic Information, Myocardial Perfusion Imaging Testing Manufacturing Base, Sales Area and Its Competitors
Table 103. GE Healthcare Myocardial Perfusion Imaging Testing Product Offered
Table 104. GE Healthcare Myocardial Perfusion Imaging Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. GE Healthcare Main Business
Table 106. GE Healthcare Latest Developments
Table 107. Pharmalucence Basic Information, Myocardial Perfusion Imaging Testing Manufacturing Base, Sales Area and Its Competitors
Table 108. Pharmalucence Myocardial Perfusion Imaging Testing Product Offered
Table 109. Pharmalucence Myocardial Perfusion Imaging Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Pharmalucence Main Business
Table 111. Pharmalucence Latest Developments
Table 112. Curium Pharma Basic Information, Myocardial Perfusion Imaging Testing Manufacturing Base, Sales Area and Its Competitors
Table 113. Curium Pharma Myocardial Perfusion Imaging Testing Product Offered
Table 114. Curium Pharma Myocardial Perfusion Imaging Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Curium Pharma Main Business
Table 116. Curium Pharma Latest Developments
Table 117. Jubilant DraxImage Basic Information, Myocardial Perfusion Imaging Testing Manufacturing Base, Sales Area and Its Competitors
Table 118. Jubilant DraxImage Myocardial Perfusion Imaging Testing Product Offered
Table 119. Jubilant DraxImage Myocardial Perfusion Imaging Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Jubilant DraxImage Main Business
Table 121. Jubilant DraxImage Latest Developments
Table 122. Atom-Hitech Basic Information, Myocardial Perfusion Imaging Testing Manufacturing Base, Sales Area and Its Competitors
Table 123. Atom-Hitech Myocardial Perfusion Imaging Testing Product Offered
Table 124. Atom-Hitech Myocardial Perfusion Imaging Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Atom-Hitech Main Business
Table 126. Atom-Hitech Latest Developments
Table 127. Dongcheng Biochemicals Basic Information, Myocardial Perfusion Imaging Testing Manufacturing Base, Sales Area and Its Competitors
Table 128. Dongcheng Biochemicals Myocardial Perfusion Imaging Testing Product Offered
Table 129. Dongcheng Biochemicals Myocardial Perfusion Imaging Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Dongcheng Biochemicals Main Business
Table 131. Dongcheng Biochemicals Latest Developments
Table 132. Jiangyuan Pharmaceutical Basic Information, Myocardial Perfusion Imaging Testing Manufacturing Base, Sales Area and Its Competitors
Table 133. Jiangyuan Pharmaceutical Myocardial Perfusion Imaging Testing Product Offered
Table 134. Jiangyuan Pharmaceutical Myocardial Perfusion Imaging Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Jiangyuan Pharmaceutical Main Business
Table 136. Jiangyuan Pharmaceutical Latest Developments
Table 1. Myocardial Perfusion Imaging Testing Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Myocardial Perfusion Imaging Testing Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Single Photon Emission Computed Tomography
Table 4. Major Players of Positron Emission Tomography
Table 5. Global Myocardial Perfusion Imaging Testing Sales by Type (2017-2022) & (K Units)
Table 6. Global Myocardial Perfusion Imaging Testing Sales Market Share by Type (2017-2022)
Table 7. Global Myocardial Perfusion Imaging Testing Revenue by Type (2017-2022) & ($ million)
Table 8. Global Myocardial Perfusion Imaging Testing Revenue Market Share by Type (2017-2022)
Table 9. Global Myocardial Perfusion Imaging Testing Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Myocardial Perfusion Imaging Testing Sales by Application (2017-2022) & (K Units)
Table 11. Global Myocardial Perfusion Imaging Testing Sales Market Share by Application (2017-2022)
Table 12. Global Myocardial Perfusion Imaging Testing Revenue by Application (2017-2022)
Table 13. Global Myocardial Perfusion Imaging Testing Revenue Market Share by Application (2017-2022)
Table 14. Global Myocardial Perfusion Imaging Testing Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Myocardial Perfusion Imaging Testing Sales by Company (2020-2022) & (K Units)
Table 16. Global Myocardial Perfusion Imaging Testing Sales Market Share by Company (2020-2022)
Table 17. Global Myocardial Perfusion Imaging Testing Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Myocardial Perfusion Imaging Testing Revenue Market Share by Company (2020-2022)
Table 19. Global Myocardial Perfusion Imaging Testing Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Myocardial Perfusion Imaging Testing Producing Area Distribution and Sales Area
Table 21. Players Myocardial Perfusion Imaging Testing Products Offered
Table 22. Myocardial Perfusion Imaging Testing Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Myocardial Perfusion Imaging Testing Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Myocardial Perfusion Imaging Testing Sales Market Share Geographic Region (2017-2022)
Table 27. Global Myocardial Perfusion Imaging Testing Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Myocardial Perfusion Imaging Testing Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Myocardial Perfusion Imaging Testing Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Myocardial Perfusion Imaging Testing Sales Market Share by Country/Region (2017-2022)
Table 31. Global Myocardial Perfusion Imaging Testing Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Myocardial Perfusion Imaging Testing Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Myocardial Perfusion Imaging Testing Sales by Country (2017-2022) & (K Units)
Table 34. Americas Myocardial Perfusion Imaging Testing Sales Market Share by Country (2017-2022)
Table 35. Americas Myocardial Perfusion Imaging Testing Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Myocardial Perfusion Imaging Testing Revenue Market Share by Country (2017-2022)
Table 37. Americas Myocardial Perfusion Imaging Testing Sales by Type (2017-2022) & (K Units)
Table 38. Americas Myocardial Perfusion Imaging Testing Sales Market Share by Type (2017-2022)
Table 39. Americas Myocardial Perfusion Imaging Testing Sales by Application (2017-2022) & (K Units)
Table 40. Americas Myocardial Perfusion Imaging Testing Sales Market Share by Application (2017-2022)
Table 41. APAC Myocardial Perfusion Imaging Testing Sales by Region (2017-2022) & (K Units)
Table 42. APAC Myocardial Perfusion Imaging Testing Sales Market Share by Region (2017-2022)
Table 43. APAC Myocardial Perfusion Imaging Testing Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Myocardial Perfusion Imaging Testing Revenue Market Share by Region (2017-2022)
Table 45. APAC Myocardial Perfusion Imaging Testing Sales by Type (2017-2022) & (K Units)
Table 46. APAC Myocardial Perfusion Imaging Testing Sales Market Share by Type (2017-2022)
Table 47. APAC Myocardial Perfusion Imaging Testing Sales by Application (2017-2022) & (K Units)
Table 48. APAC Myocardial Perfusion Imaging Testing Sales Market Share by Application (2017-2022)
Table 49. Europe Myocardial Perfusion Imaging Testing Sales by Country (2017-2022) & (K Units)
Table 50. Europe Myocardial Perfusion Imaging Testing Sales Market Share by Country (2017-2022)
Table 51. Europe Myocardial Perfusion Imaging Testing Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Myocardial Perfusion Imaging Testing Revenue Market Share by Country (2017-2022)
Table 53. Europe Myocardial Perfusion Imaging Testing Sales by Type (2017-2022) & (K Units)
Table 54. Europe Myocardial Perfusion Imaging Testing Sales Market Share by Type (2017-2022)
Table 55. Europe Myocardial Perfusion Imaging Testing Sales by Application (2017-2022) & (K Units)
Table 56. Europe Myocardial Perfusion Imaging Testing Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Myocardial Perfusion Imaging Testing Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Myocardial Perfusion Imaging Testing Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Myocardial Perfusion Imaging Testing Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Myocardial Perfusion Imaging Testing Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Myocardial Perfusion Imaging Testing Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Myocardial Perfusion Imaging Testing Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Myocardial Perfusion Imaging Testing Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Myocardial Perfusion Imaging Testing Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Myocardial Perfusion Imaging Testing
Table 66. Key Market Challenges & Risks of Myocardial Perfusion Imaging Testing
Table 67. Key Industry Trends of Myocardial Perfusion Imaging Testing
Table 68. Myocardial Perfusion Imaging Testing Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Myocardial Perfusion Imaging Testing Distributors List
Table 71. Myocardial Perfusion Imaging Testing Customer List
Table 72. Global Myocardial Perfusion Imaging Testing Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Myocardial Perfusion Imaging Testing Sales Market Forecast by Region
Table 74. Global Myocardial Perfusion Imaging Testing Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Myocardial Perfusion Imaging Testing Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Myocardial Perfusion Imaging Testing Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Myocardial Perfusion Imaging Testing Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Myocardial Perfusion Imaging Testing Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Myocardial Perfusion Imaging Testing Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Myocardial Perfusion Imaging Testing Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Myocardial Perfusion Imaging Testing Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Myocardial Perfusion Imaging Testing Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Myocardial Perfusion Imaging Testing Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Myocardial Perfusion Imaging Testing Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Myocardial Perfusion Imaging Testing Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Myocardial Perfusion Imaging Testing Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Myocardial Perfusion Imaging Testing Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Myocardial Perfusion Imaging Testing Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Myocardial Perfusion Imaging Testing Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Myocardial Perfusion Imaging Testing Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Myocardial Perfusion Imaging Testing Revenue Market Share Forecast by Application (2023-2028)
Table 92. Lantheus Basic Information, Myocardial Perfusion Imaging Testing Manufacturing Base, Sales Area and Its Competitors
Table 93. Lantheus Myocardial Perfusion Imaging Testing Product Offered
Table 94. Lantheus Myocardial Perfusion Imaging Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Lantheus Main Business
Table 96. Lantheus Latest Developments
Table 97. Cardinal Health Basic Information, Myocardial Perfusion Imaging Testing Manufacturing Base, Sales Area and Its Competitors
Table 98. Cardinal Health Myocardial Perfusion Imaging Testing Product Offered
Table 99. Cardinal Health Myocardial Perfusion Imaging Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Cardinal Health Main Business
Table 101. Cardinal Health Latest Developments
Table 102. GE Healthcare Basic Information, Myocardial Perfusion Imaging Testing Manufacturing Base, Sales Area and Its Competitors
Table 103. GE Healthcare Myocardial Perfusion Imaging Testing Product Offered
Table 104. GE Healthcare Myocardial Perfusion Imaging Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. GE Healthcare Main Business
Table 106. GE Healthcare Latest Developments
Table 107. Pharmalucence Basic Information, Myocardial Perfusion Imaging Testing Manufacturing Base, Sales Area and Its Competitors
Table 108. Pharmalucence Myocardial Perfusion Imaging Testing Product Offered
Table 109. Pharmalucence Myocardial Perfusion Imaging Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Pharmalucence Main Business
Table 111. Pharmalucence Latest Developments
Table 112. Curium Pharma Basic Information, Myocardial Perfusion Imaging Testing Manufacturing Base, Sales Area and Its Competitors
Table 113. Curium Pharma Myocardial Perfusion Imaging Testing Product Offered
Table 114. Curium Pharma Myocardial Perfusion Imaging Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Curium Pharma Main Business
Table 116. Curium Pharma Latest Developments
Table 117. Jubilant DraxImage Basic Information, Myocardial Perfusion Imaging Testing Manufacturing Base, Sales Area and Its Competitors
Table 118. Jubilant DraxImage Myocardial Perfusion Imaging Testing Product Offered
Table 119. Jubilant DraxImage Myocardial Perfusion Imaging Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Jubilant DraxImage Main Business
Table 121. Jubilant DraxImage Latest Developments
Table 122. Atom-Hitech Basic Information, Myocardial Perfusion Imaging Testing Manufacturing Base, Sales Area and Its Competitors
Table 123. Atom-Hitech Myocardial Perfusion Imaging Testing Product Offered
Table 124. Atom-Hitech Myocardial Perfusion Imaging Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Atom-Hitech Main Business
Table 126. Atom-Hitech Latest Developments
Table 127. Dongcheng Biochemicals Basic Information, Myocardial Perfusion Imaging Testing Manufacturing Base, Sales Area and Its Competitors
Table 128. Dongcheng Biochemicals Myocardial Perfusion Imaging Testing Product Offered
Table 129. Dongcheng Biochemicals Myocardial Perfusion Imaging Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Dongcheng Biochemicals Main Business
Table 131. Dongcheng Biochemicals Latest Developments
Table 132. Jiangyuan Pharmaceutical Basic Information, Myocardial Perfusion Imaging Testing Manufacturing Base, Sales Area and Its Competitors
Table 133. Jiangyuan Pharmaceutical Myocardial Perfusion Imaging Testing Product Offered
Table 134. Jiangyuan Pharmaceutical Myocardial Perfusion Imaging Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Jiangyuan Pharmaceutical Main Business
Table 136. Jiangyuan Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Myocardial Perfusion Imaging Testing
Figure 2. Myocardial Perfusion Imaging Testing Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Myocardial Perfusion Imaging Testing Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Myocardial Perfusion Imaging Testing Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Myocardial Perfusion Imaging Testing Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Single Photon Emission Computed Tomography
Figure 10. Product Picture of Positron Emission Tomography
Figure 11. Global Myocardial Perfusion Imaging Testing Sales Market Share by Type in 2021
Figure 12. Global Myocardial Perfusion Imaging Testing Revenue Market Share by Type (2017-2022)
Figure 13. Myocardial Perfusion Imaging Testing Consumed in Hospital
Figure 14. Global Myocardial Perfusion Imaging Testing Market: Hospital (2017-2022) & (K Units)
Figure 15. Myocardial Perfusion Imaging Testing Consumed in Ambulatory Care Centers
Figure 16. Global Myocardial Perfusion Imaging Testing Market: Ambulatory Care Centers (2017-2022) & (K Units)
Figure 17. Myocardial Perfusion Imaging Testing Consumed in Others
Figure 18. Global Myocardial Perfusion Imaging Testing Market: Others (2017-2022) & (K Units)
Figure 19. Global Myocardial Perfusion Imaging Testing Sales Market Share by Application (2017-2022)
Figure 20. Global Myocardial Perfusion Imaging Testing Revenue Market Share by Application in 2021
Figure 21. Myocardial Perfusion Imaging Testing Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Myocardial Perfusion Imaging Testing Revenue Market Share by Company in 2021
Figure 23. Global Myocardial Perfusion Imaging Testing Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Myocardial Perfusion Imaging Testing Revenue Market Share by Geographic Region in 2021
Figure 25. Global Myocardial Perfusion Imaging Testing Sales Market Share by Region (2017-2022)
Figure 26. Global Myocardial Perfusion Imaging Testing Revenue Market Share by Country/Region in 2021
Figure 27. Americas Myocardial Perfusion Imaging Testing Sales 2017-2022 (K Units)
Figure 28. Americas Myocardial Perfusion Imaging Testing Revenue 2017-2022 ($ Millions)
Figure 29. APAC Myocardial Perfusion Imaging Testing Sales 2017-2022 (K Units)
Figure 30. APAC Myocardial Perfusion Imaging Testing Revenue 2017-2022 ($ Millions)
Figure 31. Europe Myocardial Perfusion Imaging Testing Sales 2017-2022 (K Units)
Figure 32. Europe Myocardial Perfusion Imaging Testing Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Myocardial Perfusion Imaging Testing Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Myocardial Perfusion Imaging Testing Revenue 2017-2022 ($ Millions)
Figure 35. Americas Myocardial Perfusion Imaging Testing Sales Market Share by Country in 2021
Figure 36. Americas Myocardial Perfusion Imaging Testing Revenue Market Share by Country in 2021
Figure 37. United States Myocardial Perfusion Imaging Testing Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Myocardial Perfusion Imaging Testing Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Myocardial Perfusion Imaging Testing Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Myocardial Perfusion Imaging Testing Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Myocardial Perfusion Imaging Testing Sales Market Share by Region in 2021
Figure 42. APAC Myocardial Perfusion Imaging Testing Revenue Market Share by Regions in 2021
Figure 43. China Myocardial Perfusion Imaging Testing Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Myocardial Perfusion Imaging Testing Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Myocardial Perfusion Imaging Testing Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Myocardial Perfusion Imaging Testing Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Myocardial Perfusion Imaging Testing Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Myocardial Perfusion Imaging Testing Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Myocardial Perfusion Imaging Testing Sales Market Share by Country in 2021
Figure 50. Europe Myocardial Perfusion Imaging Testing Revenue Market Share by Country in 2021
Figure 51. Germany Myocardial Perfusion Imaging Testing Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Myocardial Perfusion Imaging Testing Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Myocardial Perfusion Imaging Testing Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Myocardial Perfusion Imaging Testing Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Myocardial Perfusion Imaging Testing Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Myocardial Perfusion Imaging Testing Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Myocardial Perfusion Imaging Testing Revenue Market Share by Country in 2021
Figure 58. Egypt Myocardial Perfusion Imaging Testing Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Myocardial Perfusion Imaging Testing Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Myocardial Perfusion Imaging Testing Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Myocardial Perfusion Imaging Testing Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Myocardial Perfusion Imaging Testing Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Myocardial Perfusion Imaging Testing in 2021
Figure 64. Manufacturing Process Analysis of Myocardial Perfusion Imaging Testing
Figure 65. Industry Chain Structure of Myocardial Perfusion Imaging Testing
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Figure 1. Picture of Myocardial Perfusion Imaging Testing
Figure 2. Myocardial Perfusion Imaging Testing Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Myocardial Perfusion Imaging Testing Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Myocardial Perfusion Imaging Testing Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Myocardial Perfusion Imaging Testing Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Single Photon Emission Computed Tomography
Figure 10. Product Picture of Positron Emission Tomography
Figure 11. Global Myocardial Perfusion Imaging Testing Sales Market Share by Type in 2021
Figure 12. Global Myocardial Perfusion Imaging Testing Revenue Market Share by Type (2017-2022)
Figure 13. Myocardial Perfusion Imaging Testing Consumed in Hospital
Figure 14. Global Myocardial Perfusion Imaging Testing Market: Hospital (2017-2022) & (K Units)
Figure 15. Myocardial Perfusion Imaging Testing Consumed in Ambulatory Care Centers
Figure 16. Global Myocardial Perfusion Imaging Testing Market: Ambulatory Care Centers (2017-2022) & (K Units)
Figure 17. Myocardial Perfusion Imaging Testing Consumed in Others
Figure 18. Global Myocardial Perfusion Imaging Testing Market: Others (2017-2022) & (K Units)
Figure 19. Global Myocardial Perfusion Imaging Testing Sales Market Share by Application (2017-2022)
Figure 20. Global Myocardial Perfusion Imaging Testing Revenue Market Share by Application in 2021
Figure 21. Myocardial Perfusion Imaging Testing Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Myocardial Perfusion Imaging Testing Revenue Market Share by Company in 2021
Figure 23. Global Myocardial Perfusion Imaging Testing Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Myocardial Perfusion Imaging Testing Revenue Market Share by Geographic Region in 2021
Figure 25. Global Myocardial Perfusion Imaging Testing Sales Market Share by Region (2017-2022)
Figure 26. Global Myocardial Perfusion Imaging Testing Revenue Market Share by Country/Region in 2021
Figure 27. Americas Myocardial Perfusion Imaging Testing Sales 2017-2022 (K Units)
Figure 28. Americas Myocardial Perfusion Imaging Testing Revenue 2017-2022 ($ Millions)
Figure 29. APAC Myocardial Perfusion Imaging Testing Sales 2017-2022 (K Units)
Figure 30. APAC Myocardial Perfusion Imaging Testing Revenue 2017-2022 ($ Millions)
Figure 31. Europe Myocardial Perfusion Imaging Testing Sales 2017-2022 (K Units)
Figure 32. Europe Myocardial Perfusion Imaging Testing Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Myocardial Perfusion Imaging Testing Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Myocardial Perfusion Imaging Testing Revenue 2017-2022 ($ Millions)
Figure 35. Americas Myocardial Perfusion Imaging Testing Sales Market Share by Country in 2021
Figure 36. Americas Myocardial Perfusion Imaging Testing Revenue Market Share by Country in 2021
Figure 37. United States Myocardial Perfusion Imaging Testing Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Myocardial Perfusion Imaging Testing Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Myocardial Perfusion Imaging Testing Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Myocardial Perfusion Imaging Testing Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Myocardial Perfusion Imaging Testing Sales Market Share by Region in 2021
Figure 42. APAC Myocardial Perfusion Imaging Testing Revenue Market Share by Regions in 2021
Figure 43. China Myocardial Perfusion Imaging Testing Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Myocardial Perfusion Imaging Testing Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Myocardial Perfusion Imaging Testing Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Myocardial Perfusion Imaging Testing Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Myocardial Perfusion Imaging Testing Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Myocardial Perfusion Imaging Testing Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Myocardial Perfusion Imaging Testing Sales Market Share by Country in 2021
Figure 50. Europe Myocardial Perfusion Imaging Testing Revenue Market Share by Country in 2021
Figure 51. Germany Myocardial Perfusion Imaging Testing Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Myocardial Perfusion Imaging Testing Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Myocardial Perfusion Imaging Testing Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Myocardial Perfusion Imaging Testing Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Myocardial Perfusion Imaging Testing Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Myocardial Perfusion Imaging Testing Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Myocardial Perfusion Imaging Testing Revenue Market Share by Country in 2021
Figure 58. Egypt Myocardial Perfusion Imaging Testing Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Myocardial Perfusion Imaging Testing Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Myocardial Perfusion Imaging Testing Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Myocardial Perfusion Imaging Testing Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Myocardial Perfusion Imaging Testing Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Myocardial Perfusion Imaging Testing in 2021
Figure 64. Manufacturing Process Analysis of Myocardial Perfusion Imaging Testing
Figure 65. Industry Chain Structure of Myocardial Perfusion Imaging Testing
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
